about
Immunotherapy for recurrent miscarriageAspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophiliaMedical treatments for incomplete miscarriageProgestogen for preventing miscarriageVitamin supplementation for preventing miscarriageMedical treatments for incomplete miscarriage (less than 24 weeks)Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndromeProgestogen for preventing miscarriageBed rest during pregnancy for preventing miscarriageThe Effects of Intravenous Immunoglobulins in Women with Recurrent Miscarriages: A Systematic Review of Randomised Trials with Meta-Analyses and Trial Sequential Analyses Including Individual Patient DataTo drive or be driven: the path of a mouse model of recurrent pregnancy lossImmunomodulation in recurrent miscarriageThe effects of immunotherapy with intravenous immunoglobulins versus no intervention, placebo, or usual care in patients with recurrent miscarriages: a protocol for a systematic review with meta-analyses, trial sequential analyses, and individual paA signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4dEvidence-based management of recurrent miscarriagesNew insights into mechanisms behind miscarriage.Chinese herbal medicine for miscarriage affects decidual micro-environment and fetal growth.Consecutive successful pregnancies subsequent to intravenous immunoglobulin therapy in a patient with recurrent spontaneous miscarriageRecurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).Risk of miscarriage among users of corticosteroid hormones: a population-based nested case-control studyRegulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium.Progesterone-mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage.Allogenic Lymphocyte Immunotherapy for Unexplained Recurrent Spontaneous Abortion: A Meta-Analysis.Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.Recommendations for the use of albumin and immunoglobulins.Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.Maternal natural killer cell immunoglobulin receptor genes and human leukocyte antigen-C ligands influence recurrent spontaneous abortion in the Han Chinese population.Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050).Active Immunisation with Partner Lymphocytes in Female Patients Who Want to Become Pregnant - Current Status.
P2860
Q24193089-DCEF780E-3BA4-4C5A-A9C9-954F2244383DQ24194917-A7963251-E078-47B0-860C-23D51961D612Q24199141-3740C3B4-B314-4D30-AD63-5A5E1677B706Q24202834-8F9EA6DF-C1E6-4C19-8A00-AD632604DECEQ24234689-B4AA0266-4BFA-46CB-B232-DDA926F4F2BFQ24240387-E3F6CCD4-999A-43B9-B6BB-5DB92EAEC20EQ24241127-5D5E5628-8BC0-4071-B20D-82A730171E43Q24243131-52AF5552-3F0B-4720-B1F2-613C37F52F74Q24246931-01E49790-2287-4827-9966-0462CDE881CFQ26777807-AF2F7612-879F-4C97-93E7-4E3997D42794Q26866038-4DE9A7DC-3217-40BD-A1BD-2D6992FB0C58Q26995890-9A19EF50-AFB1-46C2-B070-53E9B899780DQ30843055-6648E3C2-41E7-4D88-AE55-42F0CFCFA25FQ33822254-9A0E1897-B900-4B3A-A4C9-BF0228711144Q34500272-04423E70-11CC-4009-8F24-CCAA4FF8CDD1Q34784972-BA1FA162-2F02-4221-B785-40FB22AE3543Q35395913-F864E890-581A-484A-AA45-4CEA2A1BCE75Q36390989-C9EF0C50-F55A-4C1C-BC11-44E8C033BEF8Q36697714-487EE251-53BA-40E0-B529-87E24C483754Q37106222-3148D726-8988-47E2-81D3-8C6FCF526BD7Q37302327-44212248-6CE7-4BA3-B521-DFC3C6A77DDEQ37448474-C6849CD8-1847-410C-A957-44D3D7066561Q37773305-026736D8-0775-4758-81B0-782E444FE413Q38815066-9C19BA7A-4408-4C3B-ADD5-314BAC54A86EQ39235290-842AAAFB-E35E-48A5-9102-718B99EEB7D7Q42671923-5F1439F5-6702-4067-AD49-56BD695A57ADQ47550799-49A65820-3AE2-4AE2-9043-4AA0EFB1FA69Q49669924-8EC14244-56BB-41E1-92AD-C8F62195B30FQ54957684-36EA9ABD-76C6-480A-BB62-6B082185DC02Q54996293-81CE4066-E685-4000-B510-38E611CC9A3D
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Immunotherapy for recurrent miscarriage
@ast
Immunotherapy for recurrent miscarriage
@en
Immunotherapy for recurrent miscarriage
@en-gb
Immunotherapy for recurrent miscarriage
@nl
type
label
Immunotherapy for recurrent miscarriage
@ast
Immunotherapy for recurrent miscarriage
@en
Immunotherapy for recurrent miscarriage
@en-gb
Immunotherapy for recurrent miscarriage
@nl
prefLabel
Immunotherapy for recurrent miscarriage
@ast
Immunotherapy for recurrent miscarriage
@en
Immunotherapy for recurrent miscarriage
@en-gb
Immunotherapy for recurrent miscarriage
@nl
P2093
P2860
P1476
Immunotherapy for recurrent miscarriage
@en
P2093
James R Scott
T Flint Porter
Yvette LaCoursiere
P2860
P356
10.1002/14651858.CD000112.PUB2
P577
2006-04-19T00:00:00Z